Cartesian Therapeutics, Inc.
General ticker "RNAC" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $341.6M (TTM average)
Cartesian Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -7.7%.
Estimated limits based on current volatility of 2.9%: low 6.99$, high 7.41$
Factors to consider:
- Total employees count: 66 as of 2024
- Current price 30.4% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [11.49$, 28.20$]
- 2025-12-31 to 2026-12-31 estimated range: [9.81$, 24.47$]
Short-term RNAC quotes
Long-term RNAC plot with estimates
Financial data
| YTD | 2024-12-31 |
|---|---|
| Operating Revenue | $38.91MM |
| Operating Expenses | $82.81MM |
| Operating Income | $-43.90MM |
| Non-Operating Income | $-33.24MM |
| R&D Expense | $45.10MM |
| Income(Loss) | $-77.14MM |
| Taxes | $0.29MM |
| Profit(Loss)* | $-77.42MM |
| Stockholders Equity | $-6.80MM |
| Assets | $435.02MM |
| Operating Cash Flow | $-23.67MM |
| Capital expenditure | $9.09MM |
| Investing Cash Flow | $-8.74MM |
| Financing Cash Flow | $168.43MM |
| Earnings Per Share** | $-2.99 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.